2. Academic Validation
  3. In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides

In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides

  • Antimicrob Agents Chemother. 2004 Jan;48(1):337-9. doi: 10.1128/AAC.48.1.337-339.2004.
Yven Van Herrewege 1,  Jo Michiels,  Jens Van Roey,  Katrien Fransen,  Luc Kestens,  Jan Balzarini,  Paul Lewi,  Guido Vanham,  Paul Janssen
Affiliations

Affiliation

  • 1 Laboratory of Immunology, Institute of Tropical Medicine, Antwerp, Belgium. yvherrewege@itg.be
PMID: 14693562 DOI: 10.1128/AAC.48.1.337-339.2004
Abstract

The nonnucleoside Reverse Transcriptase inhibitors UC-781 and TMC120-R147681 (Dapivirine) effectively prevented human immunodeficiency virus (HIV) Infection in cocultures of monocyte-derived dendritic cells and T cells, representing primary targets in sexual transmission. Both drugs had a favorable therapeutic index. A 24-h treatment with 1,000 nM UC-781 or 100 nM TMC120-R147681 prevented cell-free HIV Infection, whereas 10-fold-higher concentrations blocked cell-associated HIV.

Figures
Products